Perspective · 15 Nov 2021
Conference abstractPublished 21 Oct 2020
The covid-19 in vivo Nanoparticle Vaccine
QED Radiations Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccine development in preventing CoVid-19 requires long development and testing time which is unacceptable because attendant lockdowns cause social unrest and potential World economic collapse. Instead of traditional vaccines, a CoVid-19 treatment of patients already tested positive is proposed using intravenous injections of lipid nanoparticles (NPs). The NP treatment includes only biodegradable lipid NPs in saline. In contrast, traditional vaccines include the inactivated virus, aluminum adjuvants, formaldehyde, antibiotics, and stabilizers, but in the bloodstream of the CoVid-19 patient, only live virus exists. UV light can inactivate the live virus, but no UV sources are known within the human body. In this regard, simple QED theory based on the Planck law claims atoms in NPs lack the heat capacity to conserve heat by an increase in temperature, and instead conserve heat from the blood into EM radiation at a wavelength depending on the NP size. e.g., 80 nm lipid NPs emit UVC (254 nm) radiation. In the manner of an in vivo vaccine, the NP treatment of UVC disinfection kills the live virus to produce the inactivated virus that acts as the antigen to elicit immunity to subsequent infection. Only lipid NPs in saline are included in the in vivo vaccine while traditional vaccine ingredients are excluded. What this means is the in vivo NP vaccine not only disinfects the patient of CoVid-19, but also prompts immunity to subsequent CoVid-19 infections. By controlling the NP dose, the UVC is held to low levels of collateral DNA damage in adjacent tissue allowing recovery by DNA repair systems
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Mar 2021
A coronavirus protein transforming into a nanoparticle, a key player for covid-19 vaccine
Conference abstract · 22 May 2023
Acceptance of booster dose of COVID-19 vaccine and its determinants among health care workers at Tikur Anbessa specialized hospital
Mini review · 9 May 2023
A Registry Linkage Study Examined the Actual Uptake of the COVID-19 Vaccine among People Who Had Previously Expressed Vaccine Hesitation
Research article · 20 Mar 2023
Effect of Covid-19 Vaccination on Menstrual Pattern Changes: A Systematic Review
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectInfectious Diseases
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Thomas Prevenslik”
